Clinical Application and Mechanism Study of Moxibustion on Immune Function Regulation of Patients with Esophageal Carcinoma of Deficiency of Qi

Henan Province Hospital of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•a. Age: 18 to 75 years old (>=18 years old, <=75 years old);
•b. Stage III and IV esophageal squamous cell carcinoma confirmed by pathology;
•c. TCM syndrome differentiation is the positive qi deficiency certificate;
•d. Patients who meet the indications of chemotherapy and agree to receive chemotherapy treatment;
•e. Physical condition score (KPS score) >= 60 points;
•f. The expected survival time is >= 3 months, the main organs are in good function, and the blood routine test standards must be met (without blood transfusion and blood products within 14 days, without using G-CSF and other hematopoietic stimulating factors to correct): HB >= 90 g / L; WBC >= 3.5 x 10^9 / L; ANC >= 1.5 x 10^9 / L; PLT >= 80 x 10^9 / L. .
•g. Patients with voluntary consent and good compliance with the informed consent;
•h. Female subjects must take effective contraceptive measures throughout the study period; during screening and throughout the study period, serum or urine pregnancy test results must be negative; male subjects should be within the period of acceptance and within 1 month after completion of chemotherapy Take effective contraception.

•a. Patients with diabetes, cardiovascular, cerebrovascular, liver, kidney, and hematopoietic system or other serious diseases;
•b. Patients with contagious infectious diseases;
•c. There are contraindications for supervised moxibustion, such as joint deformities, unfavorable movement, disabled allergy for those who cannot prone for a long time, skin surface near the superficial veins that has not healed, or bleeding after injury is unknown;
•d. According to the investigator's judgment, there are concomitant diseases that seriously endanger the patient's safety or affect the patient's completion of the study.

发起方

Henan Province Hospital of TCM